Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Albers has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Additional Iron Injection to Suckling Pigs on Hematocrit Level during the Suckling Period

    by Sarah E. Albers, Emily A. Pintens, Paige K. Isensee, Clara M. Lemanski, Young Dal Jang

    Two experiments were conducted to evaluate the effects of additional iron injection to suckling piglets on hematocrit level during the suckling period. In Experiment 1, a total of 24 piglets were allotted into 3 treatments within litter based on body weight and sex at d 1 of age. Treatments were: (1) Control: a 200 mg iron-dextran intramuscular injection only at d 0 of experiment (d 1 of age), (2) Iron100: intramuscular iron-dextran injections at d 0 (200 mg iron) and 15 (11 d before weaning) of experiment (100 mg iron), and (3) Iron200: intramuscular iron-dextran injections at d 0 (200 mg iron) and 15 of experiment (200 mg iron). In Experiment 2, a total of 20 piglets were allotted into 2 treatments within litter based on body weight and sex at d 1 to 2 of age. Treatments were: (1) Iron100b: 100 mg iron-dextran intramuscular injection at d 0 of experiment (d 1 to 2 of age), and (2) Iron200b: 200 mg iron-dextran intramuscular injection at d 0 of experiment. An additional 200 mg iron-dextran was injected to all piglets intramuscularly at d 14 of experiment (11 d before weaning). In Experiment 1, there was no difference in hematocrit levels among treatments at d 15 of experiment. Both iron treatments had greater hematocrit levels than the Control treatment at d 22 and 26 of experiment (p < 0.05). The Iron200 treatment had greater hematocrit level at d 26 of experiment (p < 0.05) and tended to have a greater increase of hematocrit levels in d 22 to 26 of experiment (p = 0.09) than the Iron100 treatment. In Experiment 2, the Iron200b treatment had greater hematocrit levels than the Iron100b treatment in d 14 and 25 (p < 0.05) of experiment. Hematocrit level changes tended to be greater in the Iron200b treatment in d 0 to 14 (p = 0.08) of experiment but lower in d 14 to 25 (p < 0.05) of experiment than the Iron100b treatment. The additional iron injection to suckling piglets increased hematocrit levels with greater values at weaning in the higher injection level whereas the increase was greater when the hematocrit level was low at the time of additional injection.


  • Open Access

    PSII-15 Effect of Secondary Iron Injection to Suckling Pigs on Growth Performance and Hematocrit Level in Suckling Period

    by Sarah Albers, Paige Isensee, Emily Pintens, Clara Lemanski, Young Dal Jang

    The objective of this study was to evaluate the effects of secondary iron injection in suckling pigs on growth performance and hematocrit level in the suckling period. At d 1 of age, a total of 24 suckling pigs from 4 litters were allotted into 3 treatments within litter (8 pigs per treatment) based on body weight and gender as follows: 1) Control: no additional iron injection, 2) Iron100: secondary intramuscular injection of 100 mg iron-dextran, and 3) Iron200: secondary intramuscular injection of 200 mg iron-dextran. The initial 200 mg iron-dextran was injected intramuscularly on d 1 of age with a second injection given to the pigs on 11 d before weaning (d 16 of age). All piglets were weaned at d 27 of age. Body weight and hematocrit level were measured at d 0, 7, and 11 (weaning) post-injection. There was no significant difference in growth performance among the treatments. The Iron100 and Iron200 treatments had greater hematocrit levels than the Control treatment at d 7 and 11 post-injection (P < 0.05) with a greater hematocrit level in the Iron200 treatment than the Iron100 treatment at d 11 post-injection (P < 0.05; 34.25, 38.75, and 41.19% for Control, Iron100 and Iron200, respectively). For changes in hematocrit level, the Iron100 and Iron200 treatments had greater increases than the Control treatment in d 0-7 and d 0-11 post-injection (P < 0.05; -1.31, 4.31, and 5.75%) with no difference between the Iron100 and Iron200 treatments. In d 7-11 post-injection, the Iron200 treatment had a greater increase in hematocrit level than the Iron100 treatment with an intermediate value in the Control treatment (P < 0.05; 0.44, -0.06 and 1.38%). In conclusion, the secondary iron injection to suckling piglets did not affect growth performance until weaning whereas the injections increased hematocrit levels resulting in a greater value at weaning in the higher level of second iron injection.

  • Open Access

    PSIII-16 The Effects of Secondary Iron Injection to Suckling Piglets Injected with Two Levels of Iron at Birth on Growth Performance and Hematocrit Level in Suckling Period

    by Sarah Albers, Paige Isensee, Emily Pintens, Clara Lemanski, Young Dal Jang

    This experiment was conducted to evaluate the effects of secondary iron injection in suckling piglets injected with 2 levels of iron at birth on growth performance and hematocrit level during the suckling period. Twenty suckling pigs from 5 litters were allotted into 2 treatments within litter (10 pigs per treatment) based on body weight and gender as follows: 1) Iron100b: intramuscular injection of 100 mg iron-dextran at birth (d 1-2 of age), and 2) Iron200b: intramuscular injection of 200 mg iron-dextran at birth. A 200 mg iron-dextran was injected to all piglets intramuscularly at d 14 after the first injection (d 15-16 of age; 11 d before weaning at d 26-27 of age). Body weight and hematocrit level were measured at d 0, 7, 14 (before second injection), 21, and 25 (weaning) after the first injection. No difference was observed in growth performance between the treatments. The Iron200b treatment had greater hematocrit levels than the Iron100b treatment at d 14 (P < 0.05; 32.50 vs. 37.40% for Iron100b and Iron200b, respectively), 21 (P = 0.06), and 25 (P < 0.05; 37.90 vs. 40.75%) after the first injection (d 0, 7, and 11 after second injection, respectively). The changes in hematocrit levels tended to be greater for the Iron200b treatment than the Iron100b treatment in d 7-14 (P = 0.08) and 0-14 (P = 0.06; 5.55 vs. 11.95%) after the first injection. After the second injection, the Iron100b treatment had greater increases (P < 0.05) in hematocrit levels than the Iron200b treatment for d 14-21 and 14-25 (5.40 vs. 3.35%) of the experiment. In conclusion, with the second injection, the 200 mg iron injection at birth had greater hematocrit levels than the 100 mg iron injection until weaning whereas the increase in hematocrit level by the second injection was greater in the 100 mg iron injection at birth than the 200 mg iron.